MedTrace Logo

Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)

NCT03513705 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4000

Last updated 2023-08-16

No results posted yet for this study

Summary

PACAP-1 will evaluate to what extent an enhanced implementation of best practices in pancreatic cancer care leads to a prolonged survival and improvement of quality of life as compared to current practice.

Conditions

  • Carcinoma, Pancreatic Ductal

Interventions

OTHER

Best practices in pancreatic cancer care

All best practices follow the current state of the Dutch guideline on pancreatic cancer and the literature.

Sponsors & Collaborators

  • Dutch Cancer Society

    collaborator OTHER

  • Comprehensive Cancer Centre The Netherlands

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Marc Besselink, Prof. Dr. · Academic Medical Center - Cancer Center Amsterdam

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-22
Primary Completion
2020-07-09
Completion
2021-07-09

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03513705 on ClinicalTrials.gov